Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Study: COV2Base-a Rare Disease by COVID Study

NCT04564274 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT04564274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04564274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Study: COV2Base-a Rare Disease by COVID Study
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
October 4, 2020
Completion date
May 20, 2022
Enrollment
1,748 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic health conditions, older age is associated with increased pathogenicity